BrainsWay Ltd BRSYF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $12.60
- Day Range
- $11.00–11.00
- 52-Week Range
- $7.95–16.84
- Bid/Ask
- $0.01 / $4,013.76
- Shares Outstanding
- 40.25M
- Market Cap
- $440.36M
- Volume/Avg
- 495 / 288
Key Statistics
- Price/Earnings (Normalized)
- 42.42
- Price/Sales
- 7.11
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 129
- Website
- https://www.brainsway.com
Valuation
|
Metric
|
BRSYF
|
|---|---|
Price/Earnings (Normalized) | 42.42 |
Price/Book Value | 5.76 |
Price/Sales | 7.11 |
Price/Cash Flow | 31.44 |
Price/Earnings
BRSYF
Financial Strength
|
Metric
|
BRSYF
|
|---|---|
Quick Ratio | 3.10 |
Current Ratio | 3.59 |
Interest Coverage | 3.44 |
Quick Ratio
BRSYF
Profitability
|
Metric
|
BRSYF
|
|---|---|
Return on Assets (Normalized) | 9.36% |
Return on Equity (Normalized) | 15.63% |
Return on Invested Capital (Normalized) | 10.91% |
Return on Assets
BRSYF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|dXy$Zq@ | LOCK|L<&y | $179B | |||
| Medtronic PLC
MDT
| LOCK|q$$K?$ | LOCK|%k>&$ | $122B | |||
| Stryker Corp
SYK
| LOCK|B$?#XPn | LOCK|XB% | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|$%>vG$> | LOCK|jdd$ | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|%b#rR?L | LOCK|G@^Dl | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|>>qp!#S | LOCK|dPs | $32B | |||
| DexCom Inc
DXCM
| LOCK|Cry%@&Fs | LOCK|Gv%p! | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|nLV | LOCK|LT | $26B | |||
| Steris PLC
STE
| LOCK|RYZqXB | LOCK|GkrP | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|gr?qPvp | LOCK|Y? | $19B |
United States